IN SILICO ANALYSIS OF PROTEIN-EXCIPIENT INTERACTIONS: A MOLECULAR DOCKING STUDY ON THERAPEUTIC IL-11
See
IN SILICO INVESTIGATION OF PHYTOCHEMICALS DERIVED FROM CATHARANTHUS ROSEUS AS POTENTIAL THERAPEUTIC AGENTS TARGETING THE A42R PROTEIN OF THE HUMAN MONKEYPOX VIRUS
See
IN SILICO APPROACH, TO STUDY THE PHYTOCHEMICALS PRESENT IN CAMELLIA SINENSIS AND WITHANIA SOMNIFERA TO TARGET MPXV VIRUS A42R FOR THE TREATMENT OF MONKEYPOX DISEASE
See
IN SILICO IDENTIFICATION AND EVALUATION OF NOVEL PAROXETINE ANALOGUES AS POTENTIAL SEROTONIN TRANSPORTER (SERT) INHIBITORS
See
In Silico ANALYSIS OF PLANT Carthamus tinctoris AGAINST INSULIN RESISTANCE
See
EXPLORING TOPOISOMERASE AS A DRUG TARGET : MOLECULAR DOCKING ANALYSIS FOR TUBERCULOSIS DISEASE DRUG REPURPOSING
See
IN SILICO INVESTIGATION OF INDIAN MEDICINAL HERBS FOR INFLUENZA MANAGEMENT: A FOCUS ON OCIMUM SANCTUM, WITHANIA SOMNIFERA, AND H1N1 NEURAMINIDASE TARGETING
See
IN SILICO SCREENING OF NATURAL COMPOUNDS AGAINST MULTIPLE DISEASE-ASSOCIATED PROTEINS IN VITILIGO: A MULTI-TARGET STRATEGEY FOR VITILIGO THERAPY
See
EXPLORING GABA AS A DRUG TARGET: MOLECULAR DOCKING ANALYSIS FOR ALZHEIMER’S DISEASE DRUG REPURPOSING
See
USING GENE-miRNA NETWORKS ANALYSIS TO IDENTIFY POSSIBILITIES IN CURRENTLY AVAILABLE MEDICATIONS FOR CHRONIC HEPATITIS-INDUCED HCC
See
EXCIPIENT DESIGN IN BIOLOGICAL FORMULATIONS: A CASE STUDY OF IL-11. AND LITERATURE REVIEW OF IL-2
See
EXPLORING MACHINE LEARNING APPROACHES IN PREDICTION OF AUTOIMMUNE DISORDERS USING EPIGENETIC MODIFICATIONS
See
TARGETING PINK1 ACTIVATION IN PARKINSON’S DISEASE: UNVEILING THERAPEUTIC POTENTIALS THROUGH DRUG REPURPOSING & IN-SILICO ANALYSIS
See
NON-CODING RNAS IN AUTOIMMUNE DISORDERS: THERAPEUTIC POTENTIALS AND INTEGRATIVE NETWORK BASED COMPUTATIONAL INSIGHTS
See
EXPLORING PHYTOCHEMICAL COMPOUNDS AGAINST GPC3 FOR OVARIAN CANCER TREATMENT: AN IN-SILICO APPROACH
See